Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese
- 49 Downloads
Prospective prediction of pharmacokinetic properties for individuals of different ethnic groups could provide useful information for the design of multiregional clinical trials. The accuracy of interethnic scaling of fraction unbound (fu) of a drug could determine in large part the predictive capability of volume of distribution as well as renal clearance. As such, exploring the interethnic extrapolation of fu from healthy Caucasian to Chinese subjects and associated effect on the scaling of volume of distribution is highly warranted.
This study assessed the interethnic scaling of fu from healthy Caucasians to Chinese by using physiologically based principles and verified the approach after examining with experimentally determined fu values of a variety of reference compounds with differing binding characteristics. Moreover, the fundamental assumption of interethnic extrapolation of volume of distribution (Vd), namely the equivalency of unbound Vd (Vd,u) across different ethnic groups, was tested on the basis of observed Vd data derived from comprehensive literature analysis and scaled fu values through qualified extrapolation method.
The interethnic extrapolation approach of fu provided a high accuracy with 94.7% scaled Chinese fu values (n = 19) being within a 1.25%-fold error range. Specifically, 100% of scaled Chinese fu values for the albumin-bound compounds and 90% for those bound to alpha 1-acid glycoprotein fell within the 1.25%-fold error range. All the percentage prediction errors of scaled Chinese fu values were ≤ 30%, with a majority of those ≤ 20%. Additionally, correlation between the prediction errors and the observed fu levels was not observed. Regarding interethnic scaling of Vd, the bodyweight-normalized Vd,u instead of Vd was similar across ethnic groups.
The current study verified for the first time the ability to scale Chinese fu from Caucasian values after examining with experimentally determined fu values of a variety of reference compounds. Similarities in bodyweight-normalized Vd,u between non-obese Caucasians and Chinese have also been shown for the first time. This investigation could greatly enhance the confidence in the interethnic extrapolation of fu and Vd from healthy non-obese Caucasian to Chinese subjects.
KeywordsInterethnic scaling Fraction unbound Volume of distribution Healthy subjects Clinical pharmacokinetics
The authors thank Dr. Yichao Yu (Department of Pharmaceutics, University of Florida) for calculating ceftaroline Vss values facilitating this analysis. The authors thank anonymous reviewers for their constructive comments and scientific input, which help us to improve the quality of manuscript significantly.
This work was financially supported in part by the National Natural Science Foundation of China (No. 81603209).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 4.Shu Y, Cheng ZN, Liu ZQ, Wang LS, Zhu B, Huang SL, Ou-Yang DS, Zhou HH (2001) Interindividual variations in levels and activities of cytochrome P-450 in liver microsomes of Chinese subjects. Acta Pharmacol Sin 22(3):283–288Google Scholar
- 5.Li GF, Yu G, Liu HX, Zheng QS (2014) Ethnic-specific in vitro–in vivo extrapolation and physiologically based pharmacokinetic approaches to predict cytochrome P450-mediated pharmacokinetics in the Chinese population: opportunities and challenges. Clin Pharmacokinet 53(2):197–202CrossRefGoogle Scholar
- 7.Bajaj G, Gupta M, Heidi Wang HG, Barrett JS, Tan M, Rupalla K, Bertz R, Sheng J (2018) Challenges and opportunities with oncology drug development in China. Clin Pharmacol Ther. https://doi.org/10.1002/cpt.1017
- 18.Wong YC, Chan K, Lau OW, Aun C, Houghton IT (1991) Protein binding characterization of pethidine and norpethidine and lack of interethnic variability. Methods Find Exp Clin Pharmacol 13(4):273–279Google Scholar
- 21.US Food and Drug Administration (FDA). Drugs@FDA database: the FDA approved drug products. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm. Accessed 15 April 2017
- 33.Lin JH (1995) Species similarities and differences in pharmacokinetics. Drug Metab Dispos 23(10):1008–1021Google Scholar
- 37.Li GF, Zheng QS, Yu Y, Zhong W, Zhou HH, Qiu F, Wang G, Yu G, Derendorf H (2019) Impact of ethnicity-specific hepatic microsomal scaling factor, liver weight, and CYP1A2 content on physiologically-based prediction of CYP1A2-mediated pharmacokinetics in young and elderly Chinese adults. Clin Pharmacokinet (Accept)Google Scholar
- 40.Li GF, Yu G, Li Y, Zheng Y, Zheng QS, Derendorf H (2018) Quantitative estimation of plasma free drug fraction in patients with varying degrees of hepatic impairment: a methodological evaluation. J Pharm Sci 107(7):1948–1956Google Scholar